Chinese Journal Of Clinical Medicine, Volume. 32, Issue 3, 350(2025)

Plasma miRNA testing in the differential diagnosis of very early-stage hepatocellular carcinoma: a multicenter real-world study

HU Jie, XU Ying, HUANG Ao, YU Lei, WANG Zheng, WANG Xiaoying, YANG Xinrong, DING Zhenbin, YE Qinghai, SHI Yinghong, QIU Shuangjian, SUN Huichuan, GAO Qiang, FAN Jia, and ZHOU Jian*
Author Affiliations
  • Department of Hepatobiliary Surgery and Liver Transplantation, Zhongshan Hospital, Fudan University, Shanghai 200032, China
  • show less
    References(9)

    [1] [1] SIEGEL R L, GIAQUINTO A N, JEMAL A. Cancer statistics, 2024[J]. CA Cancer J Clin, 2024, 74(1): 12-49.

    [3] [3] ZHENG R S, CHEN R, HAN B F, et al. Cancer incidence and mortality in China, 2022[J]. Zhonghua Zhong Liu Za Zhi, 2024, 46(3): 221-231.

    [5] [5] LEE R C, FEINBAUM R L, AMBROS V. The C. elegans heterochronic gene Lin-4 encodes small RNAs with antisense complementarity to Lin-14[J]. Cell, 1993, 75(5): 843-854.

    [6] [6] HA M J, KIM V N. Regulation of microRNA biogenesis[J]. Nat Rev Mol Cell Biol, 2014, 15(8): 509-524.

    [7] [7] BARTEL D P. MicroRNAs: target recognition and regulatory functions[J]. Cell, 2009, 136(2): 215-233.

    [8] [8] TEIXEIRA A R, FERREIRA V V, PEREIRA-DA-SILVA T, et al. The role of miRNAs in the diagnosis of stable atherosclerosis of different arterial territories: a critical review[J]. Front Cardiovasc Med, 2022, 9: 1040971.

    [9] [9] ZHOU J, YU L, GAO X, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma[J]. J Clin Oncol, 2011, 29(36): 4781-4788.

    [11] [11] HUANG P, SHI Q, NI X Y, et al. Subcentimeter hepatocellular carcinoma (HCC) on gadoxetic-acid-enhanced MRI: less frequent typical imaging features compared to 1–2 cm HCC but better prognosis after surgical resection[J]. Abdom Radiol, 2023, 48(11): 3391-3400.

    [12] [12] CHEN C J, LEE M H. Early diagnosis of hepatocellular carcinoma by multiple microRNAs: validity, efficacy, and cost-effectiveness[J]. J Clin Oncol, 2011, 29(36): 4745-4747.

    Tools

    Get Citation

    Copy Citation Text

    HU Jie, XU Ying, HUANG Ao, YU Lei, WANG Zheng, WANG Xiaoying, YANG Xinrong, DING Zhenbin, YE Qinghai, SHI Yinghong, QIU Shuangjian, SUN Huichuan, GAO Qiang, FAN Jia, ZHOU Jian. Plasma miRNA testing in the differential diagnosis of very early-stage hepatocellular carcinoma: a multicenter real-world study[J]. Chinese Journal Of Clinical Medicine, 2025, 32(3): 350

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Category:

    Received: Jun. 11, 2025

    Accepted: Aug. 22, 2025

    Published Online: Aug. 22, 2025

    The Author Email: ZHOU Jian (zhou.jian@zs-hospital.sh.cn)

    DOI:10.12025/j.issn.1008-6358.2025.20250735

    Topics